
Bio-Rad Laboratories Inc
BIO · NYSE · Healthcare / Medical Devices
Price History
Full chartMarket Stats
About
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Company Details
- SectorHealthcare
- IndustryMedical Devices
- CEOMr. Norman D. Schwartz
- Employees7.45K
- Headquarters1000 Alfred Nobel Drive, Hercules, CA, United States, 94547, USA
- Websitehttps://www.bio-rad.com
Leadership
- Mr. Norman D. SchwartzChairman & CEO · b. 1950
- Mr. Jonathan P. DiVincenzoPresident & COO · b. 1966
- Mr. Roop K. Lakkaraju CPAExecutive VP & CFO · b. 1971
- Mr. James J. BarryExecutive VP & President of Life Science Group · b. 1978
- Mr. Rajat MehtaExecutive Vice President of Global Commercial Operations · b. 1979
- Mr. Ruben ArguetaVice President of Investor Relations
- Matthew WernerSenior VP and Chief Compliance & Privacy Officer
- Ms. Courtney C. EnloeExecutive VP, General Counsel & Secretary · b. 1972
- Ms. Nanditha R. YelamanchiExecutive Vice President of Global Human Resources
- Mr. Michael CrowleyExecutive Vice President of Global Commercial Operations · b. 1962
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Analyst Ratings
- Strong Buy2
- Buy2
- Hold2
Ownership Breakdown
- Institutions
- 91.25%
- Insiders
- 16.41%
- Retail / Other
- 0.00%
Top Institutional Holders
- Arnhold & S. Bleichroeder Advisers, LLC5.21M19.49%
- BlackRock Inc1.68M6.28%
- Dimensional Fund Advisors, Inc.944.55K3.53%
- Vanguard Capital Management, LLC831.16K3.11%
- Vanguard Portfolio Management, LLC829.19K3.10%
- Ariel Investments, LLC816.75K3.05%
- Earnest Partners LLC588.73K2.20%
- State Street Corp559.57K2.09%
- Capital World Investors462.46K1.73%
- Bank of America Corp444.96K1.66%
- Capital Research Global Investors443.48K1.66%
- UBS Asset Mgmt Americas Inc426.04K1.59%
- First Pacific Advisors, LP407.36K1.52%
- Massachusetts Financial Services Company396.15K1.48%
- Geode Capital Management, LLC364.68K1.36%
Top Fund Holders
- First Eagle Global A1.88M7.03%
- American Funds SMALLCAP World A881.72K3.30%
- iShares Core S&P Mid-Cap ETF630.80K2.36%
- Vanguard MStar Total Stk Mkt Idx Invest585.98K2.19%
- Vanguard Small Cap Index424.40K1.59%
Stock Splits
- Mar 8, 20022:1
- Jun 3, 19963:2
- Jun 11, 19863:2
- Aug 1, 19853:2
- Mar 18, 19802:1